US · Healthcare

Cardiff Oncology Inc (CRDF)

Biotechnology

Cardiff Oncology Inc (CRDF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CRDF

P/E ratio

18.00

Cardiff Oncology Inc (CRDF) — FAQ

What is CRDF's P/E ratio?

The price-to-earnings (P/E) ratio for Cardiff Oncology Inc (CRDF) is 18.00 (data as of 2026-03-24).

Does Cardiff Oncology Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cardiff Oncology Inc (CRDF). Check the MyAverix Finance app for the latest dividend data.

What sector is Cardiff Oncology Inc in?

Cardiff Oncology Inc (CRDF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is CRDF listed on?

CRDF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)